Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (36)
- Effect of oral contraceptives on the urinary excretion of biochemical markers indicating vasoactive action via openalex
- doi:10.1016/0378-5122(96)81792-0 via openalex
- doi:10.3109/10641968609074764 via openalex
- doi:10.1007/s004040050229 via openalex
- doi:10.1055/s-0029-1211473 via openalex
- doi:10.1056/nejm199906103402306 via openalex
- doi:10.1146/annurev.pa.25.040185.001131 via openalex
- doi:10.1016/0090-6980(90)90092-a via openalex
- doi:10.1016/s0015-0282(98)00028-4 via openalex
- doi:10.1097/00042192-199502030-00005 via openalex
- doi:10.1046/j.1365-2362.1996.950606.x via openalex
- doi:10.1016/0378-5122(95)91222-z via openalex
- W2286826286 via openalex
- W2409719279 via openalex
- W2412498190 via openalex
- W2414991586 via openalex
- W2415424089 via openalex
- W2417810846 via openalex
- W2970268359 via openalex
- W6600373570 via openalex
- W6648463122 via openalex
- W6668469520 via openalex
- doi:10.1056/nejm199103073241001 via openalex
- doi:10.1016/0091-7435(91)90006-p via openalex
- doi:10.1016/0378-5122(93)90120-7 via openalex
- doi:10.1055/s-2007-978991 via openalex
- doi:10.1161/01.cir.75.6.1102 via openalex
- doi:10.3109/01443619409027607 via openalex
- doi:10.1016/0952-3278(94)90150-3 via openalex
- doi:10.1016/0002-9378(82)90764-5 via openalex
- doi:10.1159/000022333 via openalex
- doi:10.1016/s0029-7844(96)00379-1 via openalex
- doi:10.1016/s0140-6736(94)92405-8 via openalex
- doi:10.1016/0378-5122(95)00998-1 via openalex
- W9554769 via openalex
- doi:10.1016/s0010-7824(98)00148-6 via openalex
Cited by (8)
- New developments in oral contraception: clinical utility of estradiol valerate/dienogest (Natazia®) for contraception and for treatment of heavy menstrual bleeding: patient considerations 2012
- Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill 2010
- Dienogest: an oral progestogen for the treatment of endometriosis 2010
- Progestin effects in endometriosis treatment: new research on mechanisms 2010
- Why use of dienogest for the first contraceptive pill with estradiol? 2010
- New Progestogens 2004
- Estradiol Valerate/Dienogest 2002
- Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women 2002
Source provenance
- openalex
- last seen: 2026-05-14T06:03:08.038466+00:00
License: CC0
· commercial use OK